Once-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study

SUMMARY: BACKGROUND: The use of opioid analgesics for patients with chronic nonmalignant pain is becoming more widely accepted, and long-acting formulations are an important treatment option. AIM: To assess conversion to extended-release OROS® hydromorphone from previous stable opioid agonist therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallace, M, Rauck, R L, Moulin, D, Thipphawong, J, Khanna, S, Tudor, I C
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040191/
https://www.ncbi.nlm.nih.gov/pubmed/17877652
http://dx.doi.org/10.1111/j.1742-1241.2007.01500.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040191/
https://www.ncbi.nlm.nih.gov/pubmed/17877652
http://dx.doi.org/10.1111/j.1742-1241.2007.01500.x

Ejemplares similares